BEVESPI AEROSPHERE (AstraZeneca)
(https://bevespi.com) 📸 Data Snapshot: May 29, 2026Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Information density is exceptionally high for a product site, though it suffers from extreme concept repetition necessitated by regulatory requirements. The H1 AIMS TO OPEN AIRWAYS TO THE MAX is the primary piece of marketing fluff, while H2 headings like A maintenance treatment for adults with COPD are purely functional. Body text provides granular technical data, such as the 5-minute onset claim and 24-week clinical trial durations. However, the requirement to state it is not a rescue inhaler across every page creates a high repetition-to-new-info ratio.
Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.
📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://bevespi.com) BEVESPI AEROSPHERE® (glycopyrrolate/formoterol fumarate) Inhalation Aerosol
BEVESPI AEROSPHERE [H1] AIMS TO OPEN AIRWAYS TO THE MAX [H2] A maintenance treatment for adults with COPD. BEVESPI AEROSPHERE is a combination of two COPD medicines. When used long-term—two puffs, twice a day—BEVESPI AEROSPHERE works two ways to help open airways and keep them open. Open airways can help open your world for better breathing. [H2] It is not a rescue inhaler and is not used to treat sudden COPD symptoms. It is not for the treatment of asthma. Starting June 1, 2024, eligible patients will pay as little as $35 per month for their BEVESPI.Δ Click here to see if you are eligible and to learn more. [IMG: Savings_card] ΔTerms and conditions apply. Government restrictions exclude people enrolled in federal government insurance programs from co-pay support. Click here to see if you are eligible and to learn more. [IMG: openforbreathing_sign] [IMG: feature_logo] SCROLL [H2] HOW BEVESPI AEROSPHERE CAN HELP [IMG: BEVESPI Inhaler] BEVESPI AEROSPHERE aims to open airways to the max. BEVESPI AEROSPHERE contains two medicines that work in different ways. When used long-term twice daily, BEVESPI AEROSPHERE helps to open airways and keep them open and can make it easier to breathe. In two 24-week clinical trials, effects of BEVESPI AEROSPHERE on lung function for better breathing were shown to be greater than either of its individual medicines alone.* Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough. *Individual results may vary. BEVESPI AEROSPHERE is not a rescue inhaler and is not for use to treat sudden COPD symptoms. It is not for use in asthma. [IMG: How BEVESPI AEROSPHERE Works] [IMG: lung-icon] Learn how BEVESPI AEROSPHERE works [IMG: BEVESPI Inhaler] [H2] TAKING BEVESPI AEROSPHERE Watch a video showing you how to use your inhaler. [IMG: pink-inhaler-icon] Learn how to take BEVESPI AEROSPHERE [IMG: Could I have COPD] [H2] Could I Have COPD? Have you noticed any differences or difficulty in your breathing? Even if you generally “feel” okay, it might be worth talking to your doctor. Learn about COPD, its symptoms, what causes it, and how it can be diagnosed and treated. [IMG: clipboard-icon] What you need to know about COPD [IMG: Could I have COPD] [H2] STEP INSIDE YOUR BREATHING ROOM Resources & Support Breathing Room is a dedicated place designed to help you simplify, streamline, and manage your breathing day-to-day. [IMG: Breathing Room COPD Resources] [IMG: clipboard-icon] Explore the services and support available to you [H2] IMPORTANT SAFETY INFORMATION BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased BEVESPI AEROSPHERE is not for the treatment of asthma. It is not known if BEVESPI AEROSPHERE is safe and effective in people with asthma Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD. Always have a rescue inhaler with you to treat sudden symptoms Do not use BEVESPI AEROSPHERE if you are allergic to glycopyrrolate, formoterol fumarate, or to any of the ingredients in BEVESPI AEROSPHERE Tell your healthcare provider about all the medicines you take and about all your health conditions Do not use BEVESPI AEROSPHERE more often than prescribed Do not take BEVESPI AEROSPHERE with other medicines that contain a LABA or an anticholinergic for any reason Call your healthcare provider or get medical care right away if: Your breathing problems get worse You need to use your rescue inhaler more often than usual or your rescue inhaler doesn’t work as well at relieving symptoms BEVESPI AEROSPHERE can cause serious side effects, including: Sudden breathing problems immediately after inhaling your medicine Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of the face, mouth and tongue; breathing problems Fast or irregular heartbeat, increased blood pressure, chest pain Tremor or nervousness New or worsened eye problems, including acute narrow-angle glaucoma. Symptoms may include: eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose New or worsened urinary retention. Symptoms may include difficulty urinating, painful urination, urinating frequently, or urinating in a weak stream or drips. If you have any of these symptoms, stop taking BEVESPI AEROSPHERE and call your healthcare provider right away High blood sugar or low blood potassium Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough. Tell your healthcare provider about any side effect that bothers you or that does not go away. APPROVED USE BEVESPI AEROSPHERE is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis, emphysema, or both. BEVESPI AEROSPHERE is used as 2 inhalations, 2 times each day in the morning and in the evening, to improve symptoms of COPD for better breathing. Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD; it won't replace a rescue inhaler. BEVESPI AEROSPHERE is not for the treatment of asthma. Please read full Prescribing Information , including Patient Information and Instructions for Use . [H2] IMPORTANT SAFETY INFORMATION BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased You may report side effects related to AstraZeneca products. [IMG: USA flag] This site is intended for US Consumers only. The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about BEVESPI AEROSPHERE or COPD, talk to your doctor or pharmacist. Only you and your doctor can decide if BEVESPI AEROSPHERE is right for you. X BEVESPI_AEROSPHERE false Resume Replay
SUB-PAGE (https://bevespi.com/copd-treatment.html) How BEVESPI AEROSPHERE® (glycopyrrolate/formoterol fumarate) Can Help
[H1] HOW BEVESPI AEROSPHERE CAN HELP [IMG: twice-daily-icon] When taken as prescribed for COPD, BEVESPI AEROSPHERE can help improve your breathing starting at 5 minutes.* BEVESPI AEROSPHERE will not replace a rescue inhaler for sudden COPD symptoms. *Individual results may vary [H2] TWO MEDICINES, ONE INHALER [IMG: Video thumbnail for Bevespi Neon Signs Digital Video] Watch how BEVESPI AEROSPHERE can help open your airways for better breathing BEVESPI AEROSPHERE contains two medicines, the LAMA glycopyrrolate and the LABA formoterol fumarate, that work in different ways to help relax the muscles around your airways. When taken long-term—2 puffs, 2 times a day—BEVESPI AEROSPHERE aims to open airways to the max. BEVESPI AEROSPHERE is a pressurized metered dose inhaler (pMDI) that delivers each medicine to your lungs so they can have their effect. It is a long-term treatment that comes in the same type of inhaler as most rescue medications. Remember, BEVESPI AEROSPHERE is not for use to treat sudden COPD symptoms or for asthma. Learn why there are different types of inhalers for COPD [H2] HOW DOES BEVESPI AEROSPHERE HELP OPEN UP MY AIRWAYS? The two medicines contained within BEVESPI AEROSPHERE are called bronchodilators. One medicine helps relax the smooth muscles around the airways, and the other medicine helps prevent those muscles from tightening. The medicines can complement each other because they work in different ways. Use this guide to help you start a conversation with your doctor NEXT: How do I take BEVESPI AEROSPHERE? [H2] IMPORTANT SAFETY INFORMATION BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased BEVESPI AEROSPHERE is not for the treatment of asthma. It is not known if BEVESPI AEROSPHERE is safe and effective in people with asthma Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD. Always have a rescue inhaler with you to treat sudden symptoms Do not use BEVESPI AEROSPHERE if you are allergic to glycopyrrolate, formoterol fumarate, or to any of the ingredients in BEVESPI AEROSPHERE Tell your healthcare provider about all the medicines you take and about all your health conditions Do not use BEVESPI AEROSPHERE more often than prescribed Do not take BEVESPI AEROSPHERE with other medicines that contain a LABA or an anticholinergic for any reason Call your healthcare provider or get medical care right away if: Your breathing problems get worse You need to use your rescue inhaler more often than usual or your rescue inhaler doesn’t work as well at relieving symptoms BEVESPI AEROSPHERE can cause serious side effects, including: Sudden breathing problems immediately after inhaling your medicine Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of the face, mouth and tongue; breathing problems Fast or irregular heartbeat, increased blood pressure, chest pain Tremor or nervousness New or worsened eye problems, including acute narrow-angle glaucoma. Symptoms may include: eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose New or worsened urinary retention. Symptoms may include difficulty urinating, painful urination, urinating frequently, or urinating in a weak stream or drips. If you have any of these symptoms, stop taking BEVESPI AEROSPHERE and call your healthcare provider right away High blood sugar or low blood potassium Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough. Tell your healthcare provider about any side effect that bothers you or that does not go away. APPROVED USE BEVESPI AEROSPHERE is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis, emphysema, or both. BEVESPI AEROSPHERE is used as 2 inhalations, 2 times each day in the morning and in the evening, to improve symptoms of COPD for better breathing. Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD; it won't replace a rescue inhaler. BEVESPI AEROSPHERE is not for the treatment of asthma. Please read full Prescribing Information , including Patient Information and Instructions for Use . [H2] IMPORTANT SAFETY INFORMATION BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased You may report side effects related to AstraZeneca products. [IMG: USA flag] This site is intended for US Consumers only. The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about BEVESPI AEROSPHERE or COPD, talk to your doctor or pharmacist. Only you and your doctor can decide if BEVESPI AEROSPHERE is right for you. X BEVESPI_AEROSPHERE false Resume Replay
SUB-PAGE (https://bevespi.com/how-to-use-bevespi-inhaler.html) How to Use Your Inhaler – BEVESPI AEROSPHERE® (glycopyrrolate/formoterol fumarate) Inhalation Aerosol
[H1] TAKING BEVESPI AEROSPHERE COPD is a chronic condition that requires your attention every day. That’s why you should take BEVESPI AEROSPHERE exactly as prescribed by your doctor. It’s important that you don’t miss a dose or take more doses than prescribed. If you do miss a dose, take your next dose at the same time you normally do. Don’t stop using BEVESPI AEROSPHERE unless your health care provider tells you to, because your symptoms might come back. Remember, BEVESPI AEROSPHERE will not replace a rescue inhaler for sudden COPD symptoms. To use BEVESPI AEROSPHERE effectively: [IMG: doctor-patient] To use BEVESPI AEROSPHERE effectively: [IMG: icon-puffs] [IMG: icon-morning] MORNING [IMG: icon-evening] EVENING Do not take more than 4 puffs a day Do not use more than twice a day Your inhaler should last you 30 days if you are taking 2 puffs twice a day Use the dose indicator to monitor your doses [H2] HOW TO USE YOUR INHALER Watch this video to learn how to use your BEVESPI AEROSPHERE inhaler. X false Resume Replay You might already be familiar with the BEVESPI AEROSPHERE inhaler, which is a pressurized metered dose inhaler (pMDI)—a commonly used device similar to other inhalers you may have used. However, it’s important to remember that BEVESPI AEROSPHERE is a maintenance medication for long-term treatment of COPD and does not replace a rescue inhaler for sudden symptoms. Before starting BEVESPI AEROSPHERE, make sure you read the Instructions for Use that comes with your prescription. If you have any questions about the directions, ask your health care provider. [IMG: Preparing your inhaler] PREPARING YOUR INHALER + PREPARING YOUR INHALER Take your inhaler out of the foil pouch. Throw the foil pouch away, along with the drying packet that came with it. There are... Parts of your BEVESPI AEROSPHERE inhaler: There are five main components of your inhaler: the Cap, the Mouthpiece, the Actuator, the Canister, and the Dose Indicator. Before you start using your 30-day inhaler, it’s important that you understand how the dose indicator on your inhaler works. [IMG: inhaler-icon] Make sure that the pointer on the dose indicator is pointing to the right of the “120” mark in the display window. [IMG: inhaler-icon] After 10 puffs are delivered, the pointer will point to 120. This means that there are 120 puffs of medicine left in the canister. [IMG: inhaler-icon] After you take 10 more puffs, the pointer will be pointing between 100 and 120, meaning there are 110 puffs left in the canister. [IMG: inhaler-icon] And 10 puffs after that, the pointer will point to 100, meaning 100 puffs are left. The dose indicator display window will continue to move after every 10 puffs. The number in the dose indicator display window will continue to change after every 20 puffs. The color in the dose indicator display window will change to red when there are only 20 puffs of medicine left in your inhaler. Now let’s review priming. MORE + [IMG: Priming your inhaler for the first time] PRIMING YOUR INHALER FOR THE FIRST TIME + PRIMING YOUR INHALER FOR THE FIRST TIME To prime your inhaler, remove the cap from the mouthpiece and make sure it’s clear and free of any objects. Hold the... inhaler in the upright position, pointing away from your face, and shake the inhaler well. Now, press down firmly on the center of the dose indicator until the canister stops moving in the actuator, to release a puff of medicine from the mouthpiece. You may hear a soft click as the indicator counts down. Repeat these priming steps 3 more times. Don’t forget to shake the inhaler well before each priming puff. After priming 4 times, the dose indicator should be pointing to the right of the “120” and your inhaler is now ready to use. MORE + [IMG: Using your inhaler] USING YOUR INHALER + USING YOUR INHALER STEP 1. Remove the cap from the mouthpiece and shake the inhaler well before each use... STEP 2. Hold the inhaler with the mouthpiece pointing towards you and breathe out as fully as you comfortably can through your mouth. STEP 3. Close your lips around the mouthpiece. Tilt your head back, keeping your tongue below the mouthpiece. STEP 4. While breathing in deeply and slowly, press down on the center of the dose indicator until the canister stops moving in the actuator and a puff of medicine is released. Then, stop pressing the dose indicator. STEP 5. When you have finished breathing in, remove the mouthpiece from your mouth and hold your breath as long as you comfortably can, up to 10 seconds. Then, breathe out gently. Now, repeat the steps above to take your second puff of BEVESPI AEROSPHERE. Then, replace the cap over the mouthpiece right away after use. MORE + [IMG: Cleaning your inhaler] CLEANING YOUR INHALER + CLEANING YOUR INHALER It is very important that you clean your inhaler 1 time each week to prevent medicine from building up and blocking the spray... through the mouthpiece. STEP 1. Take the canister out of the actuator and remove the cap from the mouthpiece. Don’t clean the canister or let it get wet. STEP 2. Hold the actuator under the faucet and run warm water through it for about 30 seconds. Then turn it upside down and rinse it again through the mouthpiece for about 30 seconds. STEP 3. Shake off as much water from the actuator as you can, and look into the actuator and mouthpiece to make sure any medicine build-up has been completely washed away. If there is any build-up, repeat step 2 and this step. STEP 4. Let the actuator air-dry overnight. Remember not to put the canister back into the actuator if it’s still wet. STEP 5. When the actuator is dry, gently press the canister down in the actuator. Don’t press too hard or it could cause a puff of medicine to be released. After each cleaning, it’s important to re-prime your inhaler. This is done by pressing down on the center of the dose indicator 2 times to release a total of 2 puffs into the air, away from your face. Don't forget to shake the inhaler well before each re-priming puff. Your inhaler is now ready to use. If you do not use your BEVESPI AEROSPHERE for more than 7 days, you will need to re-prime before use, as described above. Thank you for taking the time to learn about your BEVESPI AEROSPHERE Inhaler. If you have any questions, be sure to ask your health care professional. MORE + Looking for more information on how to begin your treatment with BEVESPI AEROSPHERE? Getting started on BEVESPI AEROSPHERE NEXT: Safety and Side Effects [H2] IMPORTANT SAFETY INFORMATION BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased BEVESPI AEROSPHERE is not for the treatment of asthma. It is not known if BEVESPI AEROSPHERE is safe and effective in people with asthma Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD. Always have a rescue inhaler with you to treat sudden symptoms Do not use BEVESPI AEROSPHERE if you are allergic to glycopyrrolate, formoterol fumarate, or to any of the ingredients in BEVESPI AEROSPHERE Tell your healthcare provider about all the medicines you take and about all your health conditions Do not use BEVESPI AEROSPHERE more often than prescribed Do not take BEVESPI AEROSPHERE with other medicines that contain a LABA or an anticholinergic for any reason Call your healthcare provider or get medical care right away if: Your breathing problems get worse You need to use your rescue inhaler more often than usual or your rescue inhaler doesn’t work as well at relieving symptoms BEVESPI AEROSPHERE can cause serious side effects, including: Sudden breathing problems immediately after inhaling your medicine Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of the face, mouth and tongue; breathing problems Fast or irregular heartbeat, increased blood pressure, chest pain Tremor or nervousness New or worsened eye problems, including acute narrow-angle glaucoma. Symptoms may include: eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose New or worsened urinary retention. Symptoms may include difficulty urinating, painful urination, urinating frequently, or urinating in a weak stream or drips. If you have any of these symptoms, stop taking BEVESPI AEROSPHERE and call your healthcare provider right away High blood sugar or low blood potassium Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough. Tell your healthcare provider about any side effect that bothers you or that does not go away. APPROVED USE BEVESPI AEROSPHERE is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis, emphysema, or both. BEVESPI AEROSPHERE is used as 2 inhalations, 2 times each day in the morning and in the evening, to improve symptoms of COPD for better breathing. Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD; it won't replace a rescue inhaler. BEVESPI AEROSPHERE is not for the treatment of asthma. Please read full Prescribing Information , including Patient Information and Instructions for Use . [H2] IMPORTANT SAFETY INFORMATION BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased You may report side effects related to AstraZeneca products. [IMG: USA flag] This site is intended for US Consumers only. The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about BEVESPI AEROSPHERE or COPD, talk to your doctor or pharmacist. Only you and your doctor can decide if BEVESPI AEROSPHERE is right for you.
SUB-PAGE (https://bevespi.com/copd-management-resources.html) COPD Resources and Support | Breathing Room
[H1] Welcome to your Good care means more than just a prescription. Breathing Room is a dedicated place designed to help you simplify, streamline, and manage your breathing day-to-day. Step inside and explore the support available to you. Select one of the following sections. Sections Support and Services Living with COPD Articles Support and Services Living with COPD Articles [H3] Getting Started on BEVESPI AEROSPHERE + View More [H3] Get a Free E-Book for Breathing Tips + View More [H3] Opening up to your doctor Talk to your doctor about your treatment plan + View More [H3] UNDERSTANDING COPD— EMPHYSEMA & CHRONIC BRONCHITIS What’s the difference? + View More [H3] Do you have more than one inhaler? Know the difference between “rescue” and “maintenance” or “controller” inhalers + View More [H3] 4 COMMON TRIGGERS THAT CAN MAKE IT TOUGH TO BREATHE See what they are + View More [H3] 6 TIPS TO HELP YOU GET ACTIVE Staying active can help you breathe better + View More [H3] 5 WAYSTO ENJOY TIME with your kids or grandkids + View More [H3] GETTING AND STAYING MOTIVATED Find your motivation + View More [H3] STAY ON TRACK with your treatment Steps to staying on top of your medication + View More [H3] DIAGNOSED WITH COPD? Finding a pulmonologist may help Watch video to hear Robert’s story + View More [H2] Ins & Outs of Better Breathing Find tips to help with better breathing by checking out Breathe In&Out—a free e-book you can download now that provides you with day-to-day tips, guidance, and inspiration that can help you manage your breathing. Interested? Get your free e-book [H2] Start a Conversation Maintaining an open conversation with your doctor about your COPD may help manage your condition. But sometimes it’s hard to remember what you want to talk about or ask when you’re sitting in your doctor’s office. [H2] Understanding COPD—Emphysema & Chronic Bronchitis Both emphysema and chronic bronchitis are considered to be progressive lung diseases that fall under the general term COPD, or chronic obstructive pulmonary disease. How are they different? And why are they grouped together? Learn more [H2] “Rescue,” “Maintenance,” and “Controller” Inhalers—What’s the Difference? If you’ve been diagnosed with COPD (which includes emphysema and/or chronic bronchitis), you may hear about “rescue,” “maintenance,” or “controller” treatments or inhalers. What does this mean? Learn the difference between them [H2] 4 Common Triggers of SOB (Shortness of Breath) Feeling short of breath? Here are some possible reasons why. See the triggers [H2] How to Become More Physically Active Did you know physical activity can help your breathing? Physical activity can help improve your body's use of oxygen, helping to build your energy levels. This can mean that you're able to do more without getting breathless. Ready, set, move [H2] 5 activities you can enjoy with kids or grandkids Want to spend time with your kids or grandkids without losing your breath? Try these 5 fun activities [H2] What Inspires You Each Day? Making a personal change can be exciting, but it can be a little challenging when you have a breathing condition. Replacing long-held habits that you're pretty attached to doesn’t happen overnight. But it helps to be kind to yourself, recognize and acknowledge every small step you take, and have a guiding light that keeps you going when the going gets tough. Learn how to channel your motivation [H2] Ideas for Setting Up Your Medication Routine Taking your medication as prescribed by your health care team is just one part of keeping healthy. Let’s face it though, forgetting "what" and "when" is easy to do, especially if you take more than one medication. A simple way to get on top of your medication is to create a routine. Learn how If you have questions about BEVESPI AEROSPHERE or COPD that aren’t covered here, CONTACT 1-877-807-44661-877-807-4466 to ask a nurse. [H2] IMPORTANT SAFETY INFORMATION BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased BEVESPI AEROSPHERE is not for the treatment of asthma. It is not known if BEVESPI AEROSPHERE is safe and effective in people with asthma Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD. Always have a rescue inhaler with you to treat sudden symptoms Do not use BEVESPI AEROSPHERE if you are allergic to glycopyrrolate, formoterol fumarate, or to any of the ingredients in BEVESPI AEROSPHERE Tell your healthcare provider about all the medicines you take and about all your health conditions Do not use BEVESPI AEROSPHERE more often than prescribed Do not take BEVESPI AEROSPHERE with other medicines that contain a LABA or an anticholinergic for any reason Call your healthcare provider or get medical care right away if: Your breathing problems get worse You need to use your rescue inhaler more often than usual or your rescue inhaler doesn’t work as well at relieving symptoms BEVESPI AEROSPHERE can cause serious side effects, including: Sudden breathing problems immediately after inhaling your medicine Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of the face, mouth and tongue; breathing problems Fast or irregular heartbeat, increased blood pressure, chest pain Tremor or nervousness New or worsened eye problems, including acute narrow-angle glaucoma. Symptoms may include: eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose New or worsened urinary retention. Symptoms may include difficulty urinating, painful urination, urinating frequently, or urinating in a weak stream or drips. If you have any of these symptoms, stop taking BEVESPI AEROSPHERE and call your healthcare provider right away High blood sugar or low blood potassium Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough. Tell your healthcare provider about any side effect that bothers you or that does not go away. APPROVED USE BEVESPI AEROSPHERE is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis, emphysema, or both. BEVESPI AEROSPHERE is used as 2 inhalations, 2 times each day in the morning and in the evening, to improve symptoms of COPD for better breathing. Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD; it won't replace a rescue inhaler. BEVESPI AEROSPHERE is not for the treatment of asthma. Please read full Prescribing Information , including Patient Information and Instructions for Use . [H2] IMPORTANT SAFETY INFORMATION BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased You may report side effects related to AstraZeneca products. [IMG: USA flag] This site is intended for US Consumers only. The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about BEVESPI AEROSPHERE or COPD, talk to your doctor or pharmacist. Only you and your doctor can decide if BEVESPI AEROSPHERE is right for you.
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
This page presents a snapshot of public data from BEVESPI AEROSPHERE (AstraZeneca), captured on May 29, 2026, to show how machine logic reads Information Density signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to BEVESPI AEROSPHERE (AstraZeneca): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://bevespi.com to view the most current version of its content and see directly what this company is about and what it offers.